Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anilkumar Pillai

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
The International Journal of Neuropsychopharmacology|January 12, 2010
Chronic antipsychotic treatment: protracted decreases in phospho-TrkA levels in the rat hippocampusAlvin V Terry, Debra A Gearhart, Anilkumar Pillai, et al.
Psychiatry Research|December 9, 2009
Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolismAnvita Kale, Nilesh Naphade, Swati Sapkale, et al.
Chest|January 9, 2015
The Relationship of the Fibrinogen Cleavage Biomarker Aα-Val360 With Disease Severity and Activity in α1-Antitrypsin DeficiencyRichard I Carter, Michael J Ungurs, Anilkumar Pillai, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 7, 2007
Erythropoietin prevents haloperidol treatment-induced neuronal apoptosis through regulation of BDNFAnilkumar Pillai, Krishnan M Dhandapani, Bindu A Pillai, et al.
Brain, Behavior, and Immunity|March 10, 2025
Assessment of complement cascade components in patients with major depressive disorderBrandi Quintanilla, Dede Greenstein, Ashutosh Tripathi, et al.
Schizophrenia Research|August 29, 2009
Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patientsAnvita Kale, Sadhana Joshi, Anilkumar Pillai, et al.
Molecular Psychiatry|July 10, 2025
Opposing roles of microglial and macrophagic C3ar1 signaling in stress-induced synaptic and behavioral changesAshutosh Tripathi, Alona Bartosh, Dania Jose, et al.
Drug Discovery Today|August 23, 2022
Clinical significance and potential role of trimethylamine N-oxide in neurological and neuropsychiatric disordersSowjanya Mudimela, Narahari Koppa Vishwanath, Anilkumar Pillai, et al.
Pharmacology, Biochemistry, and Behavior|January 17, 2020
Chronic oral treatment with risperidone impairs recognition memory and alters brain-derived neurotrophic factor and related signaling molecules in ratsIndrani Poddar, Patrick M Callahan, Caterina M Hernandez, et al.
Neuropsychobiology|March 11, 2021
A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum LevelsAnthony O Ahmed, Samantha Kramer, Naama Hofman, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
The International Journal of Neuropsychopharmacology|January 12, 2010
Chronic antipsychotic treatment: protracted decreases in phospho-TrkA levels in the rat hippocampusAlvin V Terry, Debra A Gearhart, Anilkumar Pillai, et al.
Psychiatry Research|December 9, 2009
Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolismAnvita Kale, Nilesh Naphade, Swati Sapkale, et al.
Chest|January 9, 2015
The Relationship of the Fibrinogen Cleavage Biomarker Aα-Val360 With Disease Severity and Activity in α1-Antitrypsin DeficiencyRichard I Carter, Michael J Ungurs, Anilkumar Pillai, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 7, 2007
Erythropoietin prevents haloperidol treatment-induced neuronal apoptosis through regulation of BDNFAnilkumar Pillai, Krishnan M Dhandapani, Bindu A Pillai, et al.
Brain, Behavior, and Immunity|March 10, 2025
Assessment of complement cascade components in patients with major depressive disorderBrandi Quintanilla, Dede Greenstein, Ashutosh Tripathi, et al.
Schizophrenia Research|August 29, 2009
Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patientsAnvita Kale, Sadhana Joshi, Anilkumar Pillai, et al.
Molecular Psychiatry|July 10, 2025
Opposing roles of microglial and macrophagic C3ar1 signaling in stress-induced synaptic and behavioral changesAshutosh Tripathi, Alona Bartosh, Dania Jose, et al.
Drug Discovery Today|August 23, 2022
Clinical significance and potential role of trimethylamine N-oxide in neurological and neuropsychiatric disordersSowjanya Mudimela, Narahari Koppa Vishwanath, Anilkumar Pillai, et al.
Pharmacology, Biochemistry, and Behavior|January 17, 2020
Chronic oral treatment with risperidone impairs recognition memory and alters brain-derived neurotrophic factor and related signaling molecules in ratsIndrani Poddar, Patrick M Callahan, Caterina M Hernandez, et al.
Neuropsychobiology|March 11, 2021
A Meta-Analysis of Brain-Derived Neurotrophic Factor Effects on Brain Volume in Schizophrenia: Genotype and Serum LevelsAnthony O Ahmed, Samantha Kramer, Naama Hofman, et al.
Pageof 11